Critical discussion on drug efflux in Mycobacterium tuberculosis.

FEMS Microbiology Reviews
Sille RemmMarkus A Seeger

Abstract

Mycobacterium tuberculosis (Mtb) can withstand months of antibiotic treatment. An important goal of tuberculosis research is shortening the treatment to reduce the burden on patients, increase adherence to the drug regimen and thereby slow the spread of drug resistance. Inhibition of drug efflux pumps by small molecules has been advocated as a promising strategy to attack persistent Mtb and shorten therapy. Although mycobacterial drug efflux pumps have been broadly investigated, mechanistic studies are scarce. In this critical review, we shed light on drug efflux in its larger mechanistic context by considering the intricate interplay between membrane transporters annotated as drug efflux pumps, membrane energetics, efflux inhibitors and cell wall biosynthesis processes. We conclude that a great wealth of data on mycobacterial transporters is insufficient to distinguish by what mechanism they contribute to drug resistance. Recent studies suggest that some drug efflux pumps transport structural lipids of the mycobacterial cell wall and that the action of certain drug efflux inhibitors involves dissipation of the proton-motive force, thereby draining the energy source of all active membrane transporters. We propose recommendation...Continue Reading

References

Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P G Guilfoile, C R Hutchinson
Jun 30, 1988·Biochemical and Biophysical Research Communications·W T BeckA R Safa
Mar 26, 1974·Biochimica Et Biophysica Acta·G Mania
Jul 7, 1995·The Journal of Biological Chemistry·A B Shapiro, V Ling
Jan 1, 1997·Clinical and Diagnostic Laboratory Immunology·J L DoranF E Nano
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·M WilsonG K Schoolnik
Feb 8, 2000·The Journal of Antimicrobial Chemotherapy·L J PiddockV Ricci
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·P E SilvaJ A Aínsa
Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Xian-Zhi LiHiroshi Nikaido
Jul 27, 2004·Antimicrobial Agents and Chemotherapy·Maria Rosalia PascaGiovanna Riccardi
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Edward A WeinsteinHarvey Rubin
May 24, 2005·Infection and Immunity·Pilar DomenechClifton E Barry
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Maria R PascaGiovanna Riccardi
Dec 24, 2005·The Journal of Antimicrobial Chemotherapy·Santiago Ramón-GarcíaEdda De Rossi
Aug 2, 2006·Molecular Microbiology·Jacek LubelskiArnold J M Driessen
May 7, 2008·Antimicrobial Agents and Chemotherapy·Olga DanilchankaMichael Niederweis
Jul 1, 2009·Antimicrobial Agents and Chemotherapy·Santiago Ramón-GarcíaJosé A Aínsa
Jul 23, 2009·The Journal of Infectious Diseases·Jeffrey P MurryEric J Rubin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved